Ji Yeon Lee1, Saudia Ally2, Brian Kelly3, David Kays4, Lisa Thames3. 1. Department of Pharmacy, Texas Children's Hospital, Houston, Texas. 2. University of Florida College of Pharmacy, Gainesville, Florida. 3. Department of Pharmacy, University of Florida Health Shands Hospital. 4. Department of Pediatric Surgery, University of Florida Health Shands Hospital, Gainesville, Florida.
Abstract
OBJECTIVES: The aim of this study was to compare hospital length of stay and rate of infectious complications in children with perforated appendicitis based on the postoperative antibiotic administered. METHODS: This study was a retrospective analysis of children with perforated appendicitis who underwent an appendectomy at a large academic medical center from 2008 to 2013. The primary outcome was hospital length of stay. The secondary outcomes were rates of abscess formation, wound infection, and 30-day readmissions. RESULTS: One hundred and twenty-three patients were included. Sixty-six patients (53%) were administered ceftriaxone and metronidazole once daily; 57 (47%) were administered other antibiotic regimens, which consisted of single, double, or triple antibiotic therapy with a beta-lactam backbone. There was no difference between the groups in terms of postoperative length of stay (5.7 versus 5.8 days, p = 0.83), postoperative abscess rate (8% versus 4%, p = 0.57), postoperative wound infection rate (5% versus 2%, p = 0.73), and 30-day readmissions (3% versus 11%, p = 0.19). CONCLUSIONS: While there was no statistically significant difierence in the outcomes evaluated, the rate of infectious complications was twofold higher in those given ceftriaxone and metronidazole than in others. A larger prospective randomized controlled trial is warranted to better understand the risks of using these agents.
OBJECTIVES: The aim of this study was to compare hospital length of stay and rate of infectious complications in children with perforated appendicitis based on the postoperative antibiotic administered. METHODS: This study was a retrospective analysis of children with perforated appendicitis who underwent an appendectomy at a large academic medical center from 2008 to 2013. The primary outcome was hospital length of stay. The secondary outcomes were rates of abscess formation, wound infection, and 30-day readmissions. RESULTS: One hundred and twenty-three patients were included. Sixty-six patients (53%) were administered ceftriaxone and metronidazole once daily; 57 (47%) were administered other antibiotic regimens, which consisted of single, double, or triple antibiotic therapy with a beta-lactam backbone. There was no difference between the groups in terms of postoperative length of stay (5.7 versus 5.8 days, p = 0.83), postoperative abscess rate (8% versus 4%, p = 0.57), postoperative wound infection rate (5% versus 2%, p = 0.73), and 30-day readmissions (3% versus 11%, p = 0.19). CONCLUSIONS: While there was no statistically significant difierence in the outcomes evaluated, the rate of infectious complications was twofold higher in those given ceftriaxone and metronidazole than in others. A larger prospective randomized controlled trial is warranted to better understand the risks of using these agents.
Authors: Jason D Fraser; Pablo Aguayo; Charles M Leys; Scott J Keckler; Jason G Newland; Susan W Sharp; John P Murphy; Charles L Snyder; Ronald J Sharp; Walter S Andrews; George W Holcomb; Daniel J Ostlie; Shawn D St Peter Journal: J Pediatr Surg Date: 2010-06 Impact factor: 2.545
Authors: Shawn D St Peter; Danny C Little; Casey M Calkins; J Patrick Murphy; Walter S Andrews; George W Holcomb; Ronald J Sharp; Charles L Snyder; Daniel J Ostlie Journal: J Pediatr Surg Date: 2006-05 Impact factor: 2.545
Authors: Adam B Goldin; Robert S Sawin; Michelle M Garrison; Danielle M Zerr; Dimitri A Christakis Journal: Pediatrics Date: 2007-05 Impact factor: 7.124
Authors: Shawn D St Peter; Kuojen Tsao; Troy L Spilde; George W Holcomb; Susan W Sharp; J Patrick Murphy; Charles L Snyder; Ronald J Sharp; Walter S Andrews; Daniel J Ostlie Journal: J Pediatr Surg Date: 2008-06 Impact factor: 2.545